Breakthrough: FDA Greenlights Rapid Hepatitis C Test for Immediate Point-of-Care Diagnosis
Today, the U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert…
HCV Test
Read More
March 12, 2026
- IMA Releases Helpline Numbers to Support Indians Stranded in Gulf Countries
- Toxic ‘Black Rain’ in Iran Sparks Health Warning From WHO
- Supreme Court Permits Withdrawal of Life Support in First Passive Euthanasia Case
- Medtronic to Acquire Scientia Vascular in $550 Million Deal to Strengthen Stroke Care Portfolio